BioCentury | May 7, 2012
Clinical News

GMS-Classifier1 diagnostic data

...Data from an observational study of 120 patients showed that Glycominds' gMS-Classifier1 had 71% sensitivity and...
...patients (p=0.005). Data were presented at the American Academy of Neurology meeting in New Orleans. Glycominds Ltd....
BioCentury | Oct 22, 2007
Company News

Glycominds board of directors update

Glycominds Ltd. , Lod, Israel Business: Autoimmune, Microarrays Appointed: Chen Evans, a director and senior corporate VP of commercial operations at DiaSorin S.p.A., as chairman WIR Staff...
BioCentury | Jul 22, 2002
Company News

Glycominds other research news

...Binational Industrial R&D foundation to develop high throughput biochip technology to analyze glycan mediated interactions. Glycominds Ltd....
BioCentury | May 21, 2001
Emerging Company Profile

Corporate Profile

Glycominds Ltd. Maccabim, Israel Technology: Complex carbohydrate bioinformatics and arrays Disease focus: NA Clinical status: NA Founded: 1999 by Avinoam Dukler and Nir Dotan Corporate partners: None University collaborators: University of California at San Diego;...
BioCentury | May 21, 2001
Emerging Company Profile

Glycominds: I think glycan

...While many companies and institutions are setting about mapping protein-protein interactions, Glycominds Inc. is taking a...
...The company is developing technologies that map interactions between proteins and complex carbohydrates, or glycans. Glycominds...
...aspects of a protein's functionality, including folding, cellular localization, circulation half-life and immune response. Thus Glycominds...
Items per page:
1 - 5 of 5
BioCentury | May 7, 2012
Clinical News

GMS-Classifier1 diagnostic data

...Data from an observational study of 120 patients showed that Glycominds' gMS-Classifier1 had 71% sensitivity and...
...patients (p=0.005). Data were presented at the American Academy of Neurology meeting in New Orleans. Glycominds Ltd....
BioCentury | Oct 22, 2007
Company News

Glycominds board of directors update

Glycominds Ltd. , Lod, Israel Business: Autoimmune, Microarrays Appointed: Chen Evans, a director and senior corporate VP of commercial operations at DiaSorin S.p.A., as chairman WIR Staff...
BioCentury | Jul 22, 2002
Company News

Glycominds other research news

...Binational Industrial R&D foundation to develop high throughput biochip technology to analyze glycan mediated interactions. Glycominds Ltd....
BioCentury | May 21, 2001
Emerging Company Profile

Corporate Profile

Glycominds Ltd. Maccabim, Israel Technology: Complex carbohydrate bioinformatics and arrays Disease focus: NA Clinical status: NA Founded: 1999 by Avinoam Dukler and Nir Dotan Corporate partners: None University collaborators: University of California at San Diego;...
BioCentury | May 21, 2001
Emerging Company Profile

Glycominds: I think glycan

...While many companies and institutions are setting about mapping protein-protein interactions, Glycominds Inc. is taking a...
...The company is developing technologies that map interactions between proteins and complex carbohydrates, or glycans. Glycominds...
...aspects of a protein's functionality, including folding, cellular localization, circulation half-life and immune response. Thus Glycominds...
Items per page:
1 - 5 of 5